CN102225208B - 柠檬烯包合物及其制备方法 - Google Patents
柠檬烯包合物及其制备方法 Download PDFInfo
- Publication number
- CN102225208B CN102225208B CN2011101655026A CN201110165502A CN102225208B CN 102225208 B CN102225208 B CN 102225208B CN 2011101655026 A CN2011101655026 A CN 2011101655026A CN 201110165502 A CN201110165502 A CN 201110165502A CN 102225208 B CN102225208 B CN 102225208B
- Authority
- CN
- China
- Prior art keywords
- limonene
- volume
- parts
- enclose
- clathrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 title claims abstract description 211
- 235000001510 limonene Nutrition 0.000 title claims abstract description 106
- 229940087305 limonene Drugs 0.000 title claims abstract description 106
- 238000002360 preparation method Methods 0.000 title abstract description 13
- 238000010668 complexation reaction Methods 0.000 title 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 43
- 239000007788 liquid Substances 0.000 claims abstract description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 32
- 238000000034 method Methods 0.000 claims abstract description 29
- 238000001035 drying Methods 0.000 claims abstract description 14
- 238000009835 boiling Methods 0.000 claims abstract description 13
- 239000007787 solid Substances 0.000 claims abstract description 7
- 238000005406 washing Methods 0.000 claims abstract description 7
- 238000005303 weighing Methods 0.000 claims abstract description 6
- 238000001816 cooling Methods 0.000 claims abstract description 4
- 239000012065 filter cake Substances 0.000 claims abstract description 4
- 238000002156 mixing Methods 0.000 claims abstract description 4
- 239000000084 colloidal system Substances 0.000 claims description 30
- 238000003801 milling Methods 0.000 claims description 25
- 239000000203 mixture Substances 0.000 claims description 18
- 230000001476 alcoholic effect Effects 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 3
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 abstract description 47
- 229920000858 Cyclodextrin Polymers 0.000 abstract description 2
- 239000001116 FEMA 4028 Substances 0.000 abstract description 2
- 235000011175 beta-cyclodextrine Nutrition 0.000 abstract description 2
- 229960004853 betadex Drugs 0.000 abstract description 2
- 238000001914 filtration Methods 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
- 239000000341 volatile oil Substances 0.000 description 41
- 239000003921 oil Substances 0.000 description 21
- 229960004756 ethanol Drugs 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- 239000003814 drug Substances 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 210000000232 gallbladder Anatomy 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 4
- 230000006837 decompression Effects 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 229910021536 Zeolite Inorganic materials 0.000 description 3
- 229960000935 dehydrated alcohol Drugs 0.000 description 3
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 235000011837 pasties Nutrition 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000010457 zeolite Substances 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 210000001953 common bile duct Anatomy 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010051986 Pneumatosis Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- IUJDSEJGGMCXSG-UHFFFAOYSA-N Thiopental Chemical compound CCCC(C)C1(CC)C(=O)NC(=S)NC1=O IUJDSEJGGMCXSG-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 125000000396 limonene group Chemical group 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- -1 monoterpenes chemical compound Chemical class 0.000 description 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011101655026A CN102225208B (zh) | 2011-06-20 | 2011-06-20 | 柠檬烯包合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011101655026A CN102225208B (zh) | 2011-06-20 | 2011-06-20 | 柠檬烯包合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102225208A CN102225208A (zh) | 2011-10-26 |
CN102225208B true CN102225208B (zh) | 2012-07-25 |
Family
ID=44806234
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011101655026A Active CN102225208B (zh) | 2011-06-20 | 2011-06-20 | 柠檬烯包合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102225208B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105088775A (zh) * | 2015-09-11 | 2015-11-25 | 无锡市长安曙光手套厂 | 一种接枝β环糊精的释香织物及其制备方法 |
CN105200770A (zh) * | 2015-09-11 | 2015-12-30 | 无锡市长安曙光手套厂 | 一种缓慢释香织物及其制备方法 |
CN112011190B (zh) * | 2019-05-31 | 2022-05-10 | 中国石油天然气股份有限公司 | 聚合物凝胶、粒径分布单分散聚合物微球及其制备与应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1506092A (zh) * | 2002-12-09 | 2004-06-23 | 张瑞祥 | 一种治疗腹泻的香薷提取物胶囊制剂及其制备方法 |
CN1517395A (zh) * | 2003-01-16 | 2004-08-04 | 董英杰 | 茴香烯的羟丙基-β-环糊精包合物及其制剂和制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS583454A (ja) * | 1981-06-30 | 1983-01-10 | Toshiba Corp | Pbx内線コ−ルフォワ−ド方式 |
-
2011
- 2011-06-20 CN CN2011101655026A patent/CN102225208B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1506092A (zh) * | 2002-12-09 | 2004-06-23 | 张瑞祥 | 一种治疗腹泻的香薷提取物胶囊制剂及其制备方法 |
CN1517395A (zh) * | 2003-01-16 | 2004-08-04 | 董英杰 | 茴香烯的羟丙基-β-环糊精包合物及其制剂和制备方法 |
Non-Patent Citations (3)
Title |
---|
徐珍霞等."柠檬烯β-环糊精包合物的研究".《中药材》.2004,第27卷(第6期), * |
钱星文等."益妇灵胶囊中挥发油β-环糊精包合工艺的研究".《安徽医药》.2009,第13卷(第2期), * |
马春芳等."苦荞麦麸油β-环糊精包合工艺及其参数优化".《食品科学》.2010,第31卷(第6期), * |
Also Published As
Publication number | Publication date |
---|---|
CN102225208A (zh) | 2011-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101810566B (zh) | 一种丁酸氢化可的松乳膏 | |
CN102225208B (zh) | 柠檬烯包合物及其制备方法 | |
CN107213467A (zh) | 一种姜黄素磷脂复合物的制备方法 | |
JPWO2012043549A1 (ja) | アルクチゲニン含有ゴボウシ抽出物およびその製造方法 | |
CN101703468A (zh) | 维生素e油纳米乳制剂与制备方法 | |
CN101239040B (zh) | 雷公藤红素脂质体及其制备方法 | |
CN114831957A (zh) | 利用美拉德反应产物制备的甘油二酯微胶囊及其制备方法 | |
CN101301455A (zh) | 一种治疗高脂血症的中药复方姜黄固体分散体 | |
CN101530389B (zh) | 人参皂苷Rg3磷脂复合物及其制备方法 | |
CN105561329A (zh) | 水溶性辅酶Q10与α-硫辛酸复配的环糊精三元超分子包合物及制备方法 | |
CN109589410B (zh) | 一种姜黄素制剂及其制备方法 | |
CN102266568A (zh) | 一种紫杉醇的羟丙基环糊精包合物的制备方法 | |
CN104984353A (zh) | 一种栀子苷磷脂复合物固体分散体及其制备方法 | |
CN104922080A (zh) | 治疗消化系统疾病的药物艾普拉唑钠冻干粉针剂组合物 | |
JP2009143838A (ja) | 筋肉活性化剤 | |
CN109846865B (zh) | 一种姜黄素制剂及其制备方法 | |
CN103319390A (zh) | 一种前列地尔化合物及其组合物 | |
CN104288110B (zh) | 5α‑雄甾‑3β,5,6β‑三醇注射剂及其制备方法 | |
CN102670698B (zh) | 千斤拔提取物在制备防治糖尿病药物中的应用 | |
CN102058515A (zh) | 一种24-亚甲基环木菠萝醇阿魏酸酯的固体分散体及其制剂 | |
CN101081213B (zh) | 丁二酸(5-雄甾烯-17-酮-3β-羟基)二酯固体分散体及其制备方法与应用 | |
CN111330019A (zh) | 氟马西尼包合物及其制备方法和应用 | |
CN113861141B (zh) | 一种控制中药注射液类过敏反应的穿心莲内酯磺化物的制备方法 | |
CN106692216A (zh) | 一种卷柏黄酮β‑环状糊精包合物的制备方法及其应用 | |
JP2013538847A (ja) | 低血糖症のリスクなしに血糖を制御するための新規ハーブ油 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: SICHUAN EMEISHAN PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: CHENGDU RONGYAO GROUP SICHUAN CHANGWEI PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 614000 Leshan hi tech Industrial Development Zone, Yingbin Avenue, No. 6, Sichuan Patentee after: SICHUAN EMEISHAN PHARMACEUTICAL Co.,Ltd. Address before: 614000 Leshan hi tech Industrial Development Zone, Yingbin Avenue, No. 6, Sichuan Patentee before: CHENGDU RONGYAO GROUP SICHUAN CHANGWEI PHARMACEUTICAL Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 614000 Leshan hi tech Industrial Development Zone, Yingbin Avenue, No. 6, Sichuan Patentee after: Emei Mountain in Sichuan Pharmaceutical Co.,Ltd. Address before: 614000 Leshan hi tech Industrial Development Zone, Yingbin Avenue, No. 6, Sichuan Patentee before: SICHUAN EMEISHAN PHARMACEUTICAL Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Limonene inclusion complex and preparation method thereof Effective date of registration: 20200421 Granted publication date: 20120725 Pledgee: Science and Technology Branch of Leshan Commercial Bank Co.,Ltd. Pledgor: Emei Mountain in Sichuan Pharmaceutical Co.,Ltd. Registration number: Y2020980001669 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210414 Granted publication date: 20120725 Pledgee: Science and Technology Branch of Leshan Commercial Bank Co.,Ltd. Pledgor: Emei Mountain in Sichuan Pharmaceutical Co.,Ltd. Registration number: Y2020980001669 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Limonene inclusion complex and its preparation Effective date of registration: 20210521 Granted publication date: 20120725 Pledgee: Science and Technology Branch of Leshan Commercial Bank Co.,Ltd. Pledgor: Emei Mountain in Sichuan Pharmaceutical Co.,Ltd. Registration number: Y2021510000072 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20120725 Pledgee: Science and Technology Branch of Leshan Commercial Bank Co.,Ltd. Pledgor: Emei Mountain in Sichuan Pharmaceutical Co.,Ltd. Registration number: Y2021510000072 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Lemonene inclusion complex and its preparation method Granted publication date: 20120725 Pledgee: Science and Technology Branch of Leshan Commercial Bank Co.,Ltd. Pledgor: Emei Mountain in Sichuan Pharmaceutical Co.,Ltd. Registration number: Y2024510000078 |